Skip to main content

Joint funding with the British Israel Research Academic Exchange

The BHF and the British Israel Research Academic Exchange (BIRAX) co-funds research that brings together British and Israeli scientists to tackle some of the world's leading health issues, including cardiovascular disease.

Our partnership with BIRAX supports ongoing research to explore new ways to encourage cardiovascular regeneration and repair, as well as research into the impact of ageing on human health, including its interplay with heart disease and diabetes. 

If you would like to find out more visit the BIRAX website.

Awards made through the BHF-BIRAX partnership

  • 2018/19: Professor Manuel Mayr, King's College London, SP/19/4/34677. Vascular Ageing, Rejuvenation and Healthspan Extension. BHF awarded £179,975 against a total grant of £379,515 over 3 years.
  • 2016/17: Professor Andrew Howard Baker, University of Edinburgh, SP/17/3/33020. Control of endothelial cell commitment and specification by long non-coding RNA. BHF awarded £198,774 against a total grant of £399,999 over 3 years.
  • 2014/15: Professor Chris Denning, University of Nottingham, SP/15/1/31471. Gene targeted optogenetics in hPSC-cardiovascular cells for transplantation into animal models of heart dysfunction. BHF awarded £200,000 against a total grant of £399,907 over 3 years.
  • 2014/15: Professor Paul Riley, University of Oxford, SP/15/2/31472. Investigating the niche-like microenvironment of the epicardium and its role in signalling to facilitate heart regeneration. BHF awarded £200,000 against a total grant of £400,000 over 3 years.
  • 2014/15: Professor Bruno Peault, University of Edinburgh, SP/15/3/31473. Pericytes from human pluripotent stem cells for cardiac regeneration. BHF awarded £200,000 against a total grant of £397,600 over 3 years.